Pharma, BioPharma

Brainstorm’s ALS Data Fail to Persuade FDA Advisors, Who Vote Down the Stem Cell Therapy

NurOwn, Brainstorm Cell Therapeutics’ experimental stem cell therapy for ALS, did not win the backing of an independent panel of FDA advisors. Many advisory committee members said they want to see more data from another clinical trial, the same guidance the FDA has given the biotech for nearly three years.

/ at 9:33 PM
—ADVERTISEMENT—
  • Urinary system, bladder, kidney

    Pharma, BioPharma

    Once a Blockbuster Prospect, Is Travere’s Kidney Drug on Track to Become a Bust?

    Seven months after Travere Therapeutics’ flagship drug received accelerated FDA approval in a rare kidney disease, the molecule has fallen short of the key goal of its confirmatory test. It’s the small molecule’s second Phase 3 failure this year.

    / Sep 21, 2023 at 4:30 PM
  • aging, senior, old

    Consumer / Employer, Payers

    Is the ‘Age Wave’ An Opportunity or a Challenge?

    Americans are getting older, and some healthcare leaders expect this to be a challenge for the healthcare industry. Others, however, think this is an opportunity for the industry to make improvements, such as engaging adults in their care before they turn 65.

    / Sep 21, 2023 at 4:29 PM
  • Health Tech, Hospitals

    7 AI Pitfalls That Hospitals Should Avoid

    As hospitals across the nation adopt more and more AI technology, there are some common hazards of which they should be wary. During a conference presentation on Tuesday, healthcare AI expert Suchi Saria laid out seven AI pitfalls hospitals should look out for — some of these include being duped by Big Tech companies’ marketing strategies and focusing too much on administrative use cases.

    / Sep 21, 2023 at 2:21 PM
  • AI, machine learning

    Artificial Intelligence, BioPharma

    Merck KGaA Expands in AI-Driven R&D With Two Drug Discovery Deals

    Specific targets were not disclosed, but Merck KGaA is betting the artificial intelligence technologies of Exscientia and BenevolentAI will discover into new drugs for cancer, neurology, and immunology.

    / Sep 21, 2023 at 9:48 AM
  • Sponsored Post

    Harnessing the Power of Phone Interactions in Healthcare

    A human touch makes a significant difference in healthcare call interactions where an automation-dominant approach would fall short.

    / Sep 21, 2023 at 7:30 AM